Anti-hypertensive Drug Classes and Risk of New-Onset Atrial Fibrillation in Healthy Older Adults: A Post Hoc Analysis of ASPREE Trial. - Zhou Z; Fravel MA; Orchard SG; Ryan J; Zoungas S; Fitzgerald S; Brodtmann A; Beilin LJ; Wolfe R; Tonkin AM; Nelson MR; Woods RL; et al. (Drugs & aging, 2025)